Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

NutriBand (NTRB) Shares Outstanding (Weighted Average) (2018 - 2025)

NutriBand (NTRB) has disclosed Shares Outstanding (Weighted Average) for 8 consecutive years, with $12.1 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 8.6% to $12.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.1 million through Oct 2025, up 8.6% year-over-year, with the annual reading at $10.6 million for FY2025, 33.36% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $12.1 million in Q4 2025 for NutriBand, up from $11.2 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $12.1 million in Q4 2025 to a low of $457795.0 in Q1 2021.
  • Historically, Shares Outstanding (Weighted Average) has averaged $8.6 million across 5 years, with a median of $8.2 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): crashed 91.56% in 2021 and later skyrocketed 1632.85% in 2022.
  • Year by year, Shares Outstanding (Weighted Average) stood at $7.6 million in 2021, then grew by 2.82% to $7.8 million in 2022, then rose by 0.38% to $7.8 million in 2023, then soared by 41.73% to $11.1 million in 2024, then rose by 8.6% to $12.1 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for NTRB at $12.1 million in Q4 2025, $11.2 million in Q3 2025, and $11.1 million in Q2 2025.